Patents by Inventor Simon Glerup

Simon Glerup has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of Sortilin as Biomarker for Affective/Mood Disorders
    Publication number: 20160349276
    Abstract: The present invention relates to the use of Sortilin as a biomarker. In particular, Sortilin is useful as a biomarker for affective disorders. In one aspect of the invention Sortilin may be used to aid the diagnosing and to monitor disease progression in bipolar disorder and unipolar depression by measuring Sortilin levels. The invention further provides methods for informing the choice of treatment of bipolar disorder and unipolar depression by determining the levels of Sortilin.
    Type: Application
    Filed: February 6, 2015
    Publication date: December 1, 2016
    Applicant: H. Lundbeck A/S
    Inventors: Jesper Lundhede Jepsen, Anders Nykjær, Niels Peter Ole Mors, Claus Munck Petersen, Søren Dinesen Østergaard, Simon Glerup
  • Modulation of the Interaction Between SorLA and GDNF-Family Ligand Receptors
    Publication number: 20150239973
    Abstract: The present invention relates to a method to increase the survival of neurons by modulating the interaction between Sor LA and GDNF-family ligand receptors. The agent used to modulate the interaction between the SorLA and GDNF-family ligand receptors are selected from proteins, peptides, antibodies or small organic compounds. The invention also relates to a pharmaceutical compositions comprising these agent as well as the use of said agent or pharmaceutical composition in the treatment of a disease associated with the loss of neurons and/or wherein the survival of neurons are desired.
    Type: Application
    Filed: April 8, 2015
    Publication date: August 27, 2015
    Applicant: H. LUNDBECK A/S
    Inventors: Anders Nykjær, Simon Glerup, Peder Søndergaard Madsen, Claus Munck Petersen, Ditte Olsen
  • Modulation of the Interaction between SorLA and GDNF-Family Ligand Receptors
    Publication number: 20130115212
    Abstract: The present invention relates to a method to increase the survival of neurons by modulating the interaction between SorLA and GDNF-family ligand receptors. The agent used to modulate the interaction between the SorLA and GDNF-family ligand receptors are selected from proteins, peptides, antibodies or small organic compounds. The invention also relates to a pharmaceutical compositions comprising these agent as well as the use of said agent or pharmaceutical composition in the treatment of a disease associated with the loss of neurons and/or wherein the survival of neurons are desired.
    Type: Application
    Filed: June 14, 2011
    Publication date: May 9, 2013
    Applicant: LUNDBECK A/S
    Inventors: Anders Nykjær, Simon Glerup, Peder Søndergaard Madsen, Claus Munck Petersen, Ditte Olsen